Certified by Founder Lodge
Delphia Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $67,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. De
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 07 ,2024 | Series A | $67,000,000 |
Alexandria Real Estate Equities, Inc.
Nextech Invest
LS Polaris Innovation Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Adronite | $5,000,000 | (Feb 20, 2026)
SPRX | $31,000,000 | (Feb 20, 2026)
Vizzia | $35,300,400 | (Feb 20, 2026)
Altesa BioSciences, Inc. | $75,000,000 | (Feb 20, 2026)
NuCube Energy | $13,000,000 | (Feb 20, 2026)
